English | Español
Nicholas Gueguen | Jun 30, 2017

FDA gives go-ahead to use Keytruda to treat certain solid tumor cancer cases
Nicholas Gueguen | Jun 30, 2017

GlaxoSmithKline says study indicates Nucala may improve lung function in severe asthma patients
Cheyenne Dickerson | Jun 30, 2017

Study involving two drugs may open new options for treating papillary thyroid cancer
Nicholas Gueguen | Jun 30, 2017

ALS Association adds its voice against budget plan to cut funds for National ALS Registry
Nicholas Gueguen | Jun 30, 2017

Shire study sees reduction in hereditary angioedema episodes using lanadelumab
Erianne Leatherman | Jun 29, 2017

AstraZeneca’s Imfinzi gains FDA accelerated approval for bladder cancer patients
Nicholas Gueguen | Jun 29, 2017

Study suggests ways to improve autism behaviors
Nicholas Gueguen | Jun 29, 2017

Improved therapies, new medicines upping the chance cancer patients will live longer

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’